https://www.selleckchem.com/pr....oducts/Gefitinib.htm
Overall, the prognosis of SSONH is favorable, with a non-progressive course. It is essential that ophthalmologists recognize and differentiate SSONH from glaucoma to avoid misdiagnosis and unnecessary treatment.Visual orienting was studied in a patient (FM) with parietal-occipital damage due to oligodendroglioma and associated surgery, and in eighteen control participants. The ability of FM and control participants to shift attention in response to spatial landmark cues, and in response to cues that recruit endogenous orienting via en
Curtir
Comentario
Compartilhar
